Skip to main content
S&P 5007,656.98+0.86%DOW52,573.29+0.98%NASDAQ26,333.03+0.96%BTC$77,267.00+0.58%ETH$2,510.86+2.27%GOLD$4,390.00-0.39%OIL$99.99-2.43%
Smart Investors Daily
Scorpius Holdings, Inc. logo

NASDAQ · SCPX

Scorpius Holdings, Inc.

Healthcare · Biotechnology

$0.01

Up+$0.00 (+32.50%)

Updated Sep 13, 2026, 5:21 AM

SID Score

4.2/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
2.48K
P/E ratio
-0
Dividend yield
0.00%
52-week range
$0.00 – $0.16
Volume
1.22K
Avg. volume
10.45K

Price performance

SCPX price history

1M range · 0 trading sessions · Daily adjusted prices

SCPX does not have enough price history for the selected period.

Data unavailable

The requested market data was not found.

Latest SCPX news

The latest Smart Investors Daily articles mentioning SCPX.

Stock researchCompany · Overview

SCPX research

Overview

Company profile and research snapshot.

Company profile

SCORPIUS HOLDINGS INC

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
—
Implied upside
—
Analysts
—
Open full forecast

News briefing

No generated briefing is available yet.

GlobeNewswire Inc. · May 5, 2025

Scorpius Holdings Announces Corporate Update Including Cost Optimization Initiatives, Strategic Corporate Developments, and Potential Opportunities for Expansion into Southeast Asia

Scorpius Holdings, a CDMO, announced a strategic restructuring initiative to streamline operations and improve capital efficiency, expected to generate over $6 million in annualized cost savings. The company is also exploring opportunities to establish a halal-certified biomanufacturing presence in Malaysia to address the growing demand in Southeast Asia and other Muslim-majority markets.

GlobeNewswire Inc. · Aug 19, 2024

Scorpius Holdings, Inc. Announces Closing of Public Offering

Scorpius Holdings, Inc., an integrated contract development and manufacturing organization (CDMO), announced the closing of its $14.375 million public offering of common stock and pre-funded warrants. The company plans to use the net proceeds for working capital and general corporate purposes.

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By